1-3 of 3
Liunan Li, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cytogenetic Evolution (CE) In Patients (pts) with Low and Intermediate Risk Myelodysplastic Syndromes (MDS) Is Associated with Poor Prognosis

Liunan Li, MD, Elias Jabbour, MD, Gautam Borthakur, MD, Stefan Faderl, MD, Tapan Kadia, MD, Farhad Ravandi, MD, Sherry A. Pierce, RN, BS, William G. Wierda, MD, PhD, Lynne V. Abruzzo, MD, PhD, Hagop Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2010) 116 (21): 2941.
https://doi.org/10.1182/blood.V116.21.2941.2941
Published: 2010
Journal Articles

Outcome of Patients (pts) with Chronic Myeloid Leukemia (CML) After Failure to 2 nd and 3 rd Tyrosine Kinase Inhibitors (TKIs)

Liunan Li, MD, Hagop Kantarjian, MD, Meng Zhao, MD, Susan O'Brien, MD, Elias Jabbour, MD, Alfonso Quintás-Cardama, MD, Elizabeth Burton, Stefan Faderl, MD, Alessandra Ferrajoli, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2010) 116 (21): 1238.
https://doi.org/10.1182/blood.V116.21.1238.1238
Published: 2010
Journal Articles

Langerhans Cells and T Cells in Langerhans Cell Histiocytosis Have Distinct Cytokine and Growth Factor Gene Expression Profiles Depending on the Clinical Risk Groups.

Kenneth L. McClain, MD PhD, Xiao-tian Yan, MD PhD, Liunan Li, MD, John Hicks, MD PhD DDS, Leif E. Peterson, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 3455.
https://doi.org/10.1182/blood.V104.11.3455.3455
Published: 2004